The Cox regression model analysis for the MSH6 polymorphism showed a two-fold increase in the hazard ratio and a corresponding poor outcome for these lung cancer patients (HR = 2.28; MST = 4.9; p = 0.03) (Supplementary Fig. 1). This evidence concerns the gene MSH6 and lung carcinoma.